Viral Hepatitis

This report presents recommendations for postexposure interventions to prevent hepatitis B virus, hepatitis C virus, or HIV infections and tetanus in persons wounded in bombings or events causing mass casualties. During such events, wounded persons may be exposed to blood, body fluids, or tissue from other injured persons, putting them at risk for bloodborne infections.

This report describes the burden of acute disease attributed to infection with the hepatitis A, hepatitis B, and hepatitis C viruses, and describes acute disease trends in recent years. Cases of acute viral hepatitis are reported weekly by state and territorial health departments to CDC's National Notifiable Diseases Surveillance System. The report includes the methods of collecting data, definitions for acute viral hepatitis, and analyses.

This information sheet, for the general public, discusses the hepatitis B virus (HBV). It explains HBV, risk factors for contracting HBV, transmission, symptoms, diagnosis, and treatment of acute and chronic HBV infection. It discusses ways of preventing HBV including vaccination, and provides a list of facts about the disease.

This YouTube video is a public service announcement that encourages individuals including pregnant women to get tested, and to have their babies vaccinated for hepatitis B.

This YouTube video contains a series of Public Service Announcements (PSA), encouraging individuals including pregnant women to get tested, and to have their babies vaccinated for hepatitis B.

This pamphlet provides information about hepatitis B, a viral disease that affects the liver. It discusses the liver and how it is affected by the hepatitis B virus (HBV), what is chronic hepatitis B, who gets HBV, its transmission and symptoms, diagnosis, and treatment such as liver transplantation if chronic hepatitis B causes liver failure. The pamphlet also discusses HBV prevention including vaccination, what to do if exposed to HBV, getting tested and early treatment to prevent liver damage, and participating in clinical trials. The pamphlet also provides contacts for more information.

This report contains surveillance data on the incidence of viral hepatitis A, B, and C in the United States. It lists the number of acute clinical cases reported, estimated number of acute clinical cases, estimated number of new infections, number of persons living with chronic infection, annual number of chronic liver disease deaths associated with viral hepatitis, and percentage of persons ever infected with hepatitis A, B, and C for the years 2002 to 2007.

This report provides information on the National Immunization Survey (NIS) which estimated vaccination coverage among children aged 19-35 months for 50 states and selected local areas. It describes the 2008 NIS coverage estimates for the 4:3:1:3:3:1 series and individual vaccines, 7-valent pneumococcal conjugate vaccine, =2 dose of Hepatitis A vaccine, and hepatitis B vaccine among children born during January 2005 - June 2007. Results demonstrate that the nation’s immunization program remained successful in maintaining high vaccination rates among young children.

This report contains recommendations by the Committee on the Prevention and Control of Viral Hepatitis Infections of the National Academies of the Institute of Medicine, on prevention and control of hepatitis B and hepatitis C in the United States. The committee identified the underlying factors that impede current efforts to prevent and control these diseases.

This Power Point presentation contains 181 slides that provide guidelines for the prevention and control of TB in correctional facilities, as recommended by CDC.